Response to Comment—Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology

Clicks: 305
ID: 82219
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 3 articles by views in dentistry journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We read the commentary by Fusco et al [...]
Reference Key
raje2019responsedentistry Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Raje, Noopur;Terpos, Evangelos;Jandial, Danielle D.;
Journal dentistry journal
Year 2019
DOI
DOI not found
URL
https://www.mdpi.com/2304-6767/7/2/54
Keywords
Medicine Dentistry neoplasms. tumors. oncology. including cancer and carcinogens public aspects of medicine diseases of the respiratory system internal medicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.